<SEC-DOCUMENT>0001437749-22-011845.txt : 20220511
<SEC-HEADER>0001437749-22-011845.hdr.sgml : 20220511
<ACCEPTANCE-DATETIME>20220511095745
ACCESSION NUMBER:		0001437749-22-011845
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20220510
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220511
DATE AS OF CHANGE:		20220511

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DYADIC INTERNATIONAL INC
		CENTRAL INDEX KEY:			0001213809
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				450486747
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32513
		FILM NUMBER:		22912407

	BUSINESS ADDRESS:	
		STREET 1:		140 INTRACOASTAL POINTE DRIVE
		STREET 2:		SUITE 404
		CITY:			JUPITER
		STATE:			FL
		ZIP:			33477
		BUSINESS PHONE:		561-743-8333

	MAIL ADDRESS:	
		STREET 1:		140 INTRACOASTAL POINTE DRIVE
		STREET 2:		SUITE 404
		CITY:			JUPITER
		STATE:			FL
		ZIP:			33477

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CCP WORLDWIDE INC
		DATE OF NAME CHANGE:	20030110
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>dyai20220216_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:rr="http://xbrl.sec.gov/rr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:dyai="http://www.dyai.com/20220510"><head><!-- Generated by ThunderDome Portal - 5/11/2022 1:26:33 PM -->
	<title>dyai20220216_8k.htm</title>
	<!-- Generated by ThunderDome Portal - 5/11/2022 1:26:33 PM -->
<meta http-equiv="Content-Type" content="text/html" /></head>
<body style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding: 0in 0.1in; cursor: auto;"><div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="d20228K" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d20228K" name="dei:EntityCentralIndexKey">0001213809</ix:nonNumeric>

</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="dyai-20220510.xsd" xlink:type="simple" />
</ix:references>
<ix:resources>
<xbrli:context id="d20228K">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001213809</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2022-05-10</xbrli:startDate>
<xbrli:endDate>2022-05-10</xbrli:endDate>
</xbrli:period>
</xbrli:context>


</ix:resources>
</ix:header>
</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 16pt; margin: 0pt; text-align: center;"><b>UNITED STATES</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 16pt; margin: 0pt; text-align: center;"><b>SECURITIES AND EXCHANGE COMMISSION</b></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Washington, D.C. 20549</b></div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:bottom;width:32.9%;">&#xa0;</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:34.1%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:33%;">&#xa0;</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 18pt; margin: 0pt; text-align: center;"><b>FORM <ix:nonNumeric contextRef="d20228K" name="dei:DocumentType"><b>8-K</b></ix:nonNumeric></b></div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: &quot;Times New Roman&quot;; font-size: 14pt;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;; font-size: 14pt;">
			<td style="vertical-align: bottom; width: 32.9%; font-family: &quot;Times New Roman&quot;; font-size: 14pt;">&#xa0;</td>
			<td style="vertical-align: bottom; border-bottom: 1px solid rgb(0, 0, 0); width: 34.1%; font-family: &quot;Times New Roman&quot;; font-size: 14pt;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 33%; font-family: &quot;Times New Roman&quot;; font-size: 14pt;">&#xa0;</td>
		</tr>

</tbody></table>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>CURRENT REPORT</b></div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Pursuant to Section 13 or 15(d) of the</b></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Securities Exchange Act of 1934</b></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>&#xa0;</b></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Date of Report (date of earliest event reporte<span style="background-color:#ffffff;">d): <ix:nonNumeric contextRef="d20228K" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate"><b><span style="background-color:#ffffff;"><b><span style="background-color:#ffffff;"><span style="text-decoration: underline;"><span style="font-family:Times New Roman;font-size:12pt;">May 10</span></span></span></b></span><span style="background-color:#ffffff;"><b><span style="background-color:#ffffff;"><span style="text-decoration: underline;"><span style="font-family:Times New Roman;font-size:12pt;">, 2022</span></span></span></b></span></b></ix:nonNumeric></span></b></div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:bottom;width:32.9%;">&#xa0;</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:34.1%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:33%;">&#xa0;</td>
		</tr>

</tbody></table>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:18pt;margin:0pt;text-align:center;"><ix:nonNumeric contextRef="d20228K" name="dei:EntityRegistrantName"><b>Dyadic International, Inc.</b></ix:nonNumeric></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Exact name of registrant as specified in its charter)</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:bottom;width:32.9%;">&#xa0;</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:34.1%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:33%;">&#xa0;</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:top;width:33.1%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:2.25pt;margin-top:0pt;text-align:center;"><ix:nonNumeric contextRef="d20228K" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode"><b>Delaware</b></ix:nonNumeric></div>

			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:2.25pt;margin-top:0pt;text-align:center;">(State or other jurisdiction of incorporation or organization)</div>
			</td>
			<td style="vertical-align:top;width:34.3%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:2.25pt;margin-top:0pt;text-align:center;"><ix:nonNumeric contextRef="d20228K" name="dei:EntityFileNumber"><b>000-55264</b></ix:nonNumeric></div>

			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:2.25pt;margin-top:0pt;text-align:center;">(Commission File Number)</div>
			</td>
			<td style="vertical-align:top;width:33.1%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:2.25pt;margin-top:0pt;text-align:center;"><ix:nonNumeric contextRef="d20228K" name="dei:EntityTaxIdentificationNumber"><b>45-0486747</b></ix:nonNumeric></div>

			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:2.25pt;margin-top:0pt;text-align:center;">(I.R.S. Employer Identification Number)</div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:bottom;width:100.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><ix:nonNumeric contextRef="d20228K" name="dei:EntityAddressAddressLine1"><b>140 Intracoastal Pointe Drive, Suite 404</b></ix:nonNumeric><br />
			<ix:nonNumeric contextRef="d20228K" name="dei:EntityAddressCityOrTown"><b>Jupiter</b></ix:nonNumeric><b>, <ix:nonNumeric contextRef="d20228K" name="dei:EntityAddressStateOrProvince"><b>FL</b></ix:nonNumeric> <ix:nonNumeric contextRef="d20228K" name="dei:EntityAddressPostalZipCode"><b>33477</b></ix:nonNumeric></b></div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:bottom;width:100.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 1.1pt;text-align:center;">(Address of principal executive offices and zip code)</div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:bottom;width:100.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 1.1pt;text-align:center;"><b>(<ix:nonNumeric contextRef="d20228K" name="dei:CityAreaCode"><b>561</b></ix:nonNumeric>) <ix:nonNumeric contextRef="d20228K" name="dei:LocalPhoneNumber"><b>743-8333</b></ix:nonNumeric></b></div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:bottom;width:100.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 1.1pt;text-align:center;">(Registrant&#8217;s telephone number, including area code)</div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:middle;width:100.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 2.25pt;text-align:center;"><b>N/A</b></div>

			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 2.25pt;text-align:center;"><b>(Former Name or Former Address, if Changed Since Last Report)</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:middle;width:7%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 1.1pt;text-align:center;"><ix:nonNumeric contextRef="d20228K" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:middle;width:93.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:2.25pt;margin-right:0pt;margin-top:0pt;text-align:left;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:7%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 1.1pt;text-align:center;"><ix:nonNumeric contextRef="d20228K" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:middle;width:93.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:2.25pt;margin-right:0pt;margin-top:0pt;text-align:left;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:7%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 1.1pt;text-align:center;"><ix:nonNumeric contextRef="d20228K" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:middle;width:93.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:2.25pt;margin-right:0pt;margin-top:0pt;text-align:left;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:7%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 1.1pt;text-align:center;"><ix:nonNumeric contextRef="d20228K" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:middle;width:93.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:2.25pt;margin-right:0pt;margin-top:0pt;text-align:left;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:bottom;width:100.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:2.25pt;margin-right:0pt;margin-top:0pt;text-align:left;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:100.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:2.25pt;margin-top:0pt;text-align:right;">Emerging growth company <ix:nonNumeric contextRef="d20228K" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:100.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:2.25pt;margin-right:0pt;margin-top:0pt;text-align:left;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Securities registered pursuant to Section 12(b) of the Act</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:39.4%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:2.25pt;margin-top:0pt;text-align:left;">Title of each class</div>
			</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:19.9%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 2.25pt;text-align:center;">Trading Symbol(s)</div>
			</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:41.2%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 2.25pt;text-align:center;">Name of each exchange on which registered</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:39.4%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:2.25pt;margin-top:0pt;text-align:left;"><ix:nonNumeric contextRef="d20228K" name="dei:Security12bTitle">Common Stock</ix:nonNumeric>, par value $0.001 per share</div>
			</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:19.9%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 2.25pt;text-align:center;"><ix:nonNumeric contextRef="d20228K" name="dei:TradingSymbol">DYAI</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:41.2%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt 2.25pt;text-align:center;">The <ix:nonNumeric contextRef="d20228K" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric> Stock Market LLC</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>&#xa0;</b></div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 10pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 10pt; text-indent: -9pt;"><b>Item 1.01. Entry into a Material Definitive Agreement.</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 10pt; text-indent: -9pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 10pt; text-indent: -9pt;"><span style="background-color:#ffffff;">On May 10, 2022, Dyadic</span> International (USA), Inc., a subsidiary of Dyadic International, Inc., (hereinafter collectively referred to as &#8220;Dyadic&#8221; or the &#8220;Company&#8221;) entered into a&#xa0;Joint Development Agreement (the "Agreement&#8221;) with Leprino Foods Company (&#8220;LFC&#8221;), effective May 12, 2022.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 10pt; text-indent: -9pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Under the terms and conditions of the Agreement, Dyadic and LFC will&#xa0;develop and manufacture a number of animal free ingredient products using Dyadic&#8217;s biotechnologies.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:top;width:18pt;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</div>
			</td>
			<td style="vertical-align:top;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The research project will be fully funded by LFC&#xa0;up to &#8364;3.6 million euros.</div>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:top;width:18pt;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</div>
			</td>
			<td style="vertical-align:top;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Dyadic to develop its proprietary production cell lines for the manufacture of animal free ingredient product candidates.</div>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:top;width:18pt;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</div>
			</td>
			<td style="vertical-align:top;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Dyadic will receive certain defined &#8220;Success Fees&#8221;, upon reaching certain productivity and activity levels and milestones at different stages of the collaboration.</div>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tbody><tr>
			<td style="vertical-align:top;width:18pt;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</div>
			</td>
			<td style="vertical-align:top;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Dyadic will receive a &#8220;Commercialization Fee&#8221;&#xa0;of low eight figures upon commercialization, and a royalty payment of low single digits based on commercial sales.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The foregoing description of the Agreement is only a summary of the material terms thereof, does not purport to be complete and is qualified in its entirety by reference to the full text of the Agreement, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b><span style="background-color:#ffffff;">Item 8.01 Other Events</span></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><span style="background-color:#ffffff;">On May 11, 2022,&#xa0;the Company issued a press release regarding the Agreement. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference, other than the third paragraph of such press release.</span></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt -3pt; text-indent: 18pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td colspan="3" style="vertical-align:middle;width:100.5%;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 2pt; text-align: left;"><b><span style="background-color:#ffffff;">Item 9.01 Financial Statements and Exhibits</span></b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:24.3%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:2.25pt;margin-right:0pt;margin-top:0pt;text-align:left;"><span style="background-color:#ffffff;">(d) Exhibits</span></div>
			</td>
			<td style="vertical-align:bottom;width:0.8%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:75.4%;">&#xa0;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:middle;width:100.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:2.25pt;margin-right:0pt;margin-top:0pt;text-align:left;"><span style="background-color:#ffffff;">The following exhibit is being filed herein:</span></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:24.3%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:2.25pt;margin-top:0pt;text-align:center;"><b><span style="background-color:#ffffff;">Exhibit</span></b></div>

			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:2.25pt;margin-top:0pt;text-align:center;"><span style="text-decoration: underline;"><b><span style="background-color:#ffffff;">Number</span></b></span></div>
			</td>
			<td style="vertical-align:bottom;width:0.8%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:75.4%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:2.25pt;margin-right:0pt;margin-top:0pt;text-align:left;"><span style="text-decoration: underline;"><b><span style="background-color:#ffffff;">Description</span></b></span></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:24.3%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.8%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:75.4%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 24.3%; text-align: center;"><span style="background-color:#ffffff;">10.1</span><sup style="vertical-align:top;line-height:120%;font-size:pt"><span style="background-color:#ffffff;">(1)</span></sup></td>
			<td style="vertical-align:bottom;width:0.8%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:75.4%;"><a href="ex_336879.htm" style="-sec-extract:exhibit;"><span style="background-color:#ffffff;">Joint Development Agreement dated May&#xa0;10, 2022</span></a></td>
		</tr>
		<tr>
			<td style="vertical-align:top; width:24.3%; text-align:center"><span style="background-color:#ffffff;">99.1</span></td>
			<td style="vertical-align:bottom; width:0.8%">&#xa0;</td>
			<td style="vertical-align:bottom; width:75.4%"><a href="ex_336880.htm" style="-sec-extract:exhibit;"><span style="background-color:#ffffff;">Press release dated May 11, 2022</span></a></td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 24.3%; text-align: center;"><span style="background-color:#ffffff;">104</span></td>
			<td style="vertical-align:bottom;width:0.8%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:75.4%;"><span style="background-color:#ffffff;">Cover page Interactive Data File (embedded within the Inline XBRL document)</span></td>
		</tr>

</tbody></table>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt"><span style="background-color:#ffffff;">(1)</span></sup><span style="background-color:#ffffff;">&#xa0;In accordance with Item 601(b)(10) of Regulation S-K, certain provisions or terms of the Agreement&#xa0;have been redacted.&#xa0;The Company will provide an unredacted copy of the exhibit on a supplemental basis to the SEC or its staff upon request.</span></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b><span style="background-color:#ffffff;">SIGNATURE</span></b></div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-indent: 45pt;"><span style="background-color:#ffffff;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><span style="background-color:#ffffff;">Date: May 11, 2022</span></div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width:39.5%;text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt;">

		<tbody><tr>
			<td colspan="2" style="vertical-align:bottom;width:101.4%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:2.25pt;margin-right:0pt;margin-top:0pt;text-align:left;"><b>Dyadic International, Inc.</b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:21.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:79.9%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:21.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:2.25pt;margin-right:0pt;margin-top:0pt;text-align:left;"><b>By:</b></div>
			</td>
			<td style="vertical-align:bottom;border-bottom:solid 1px #000000;;width:79.9%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:2.25pt;margin-right:0pt;margin-top:0pt;text-align:left;">/s/ Mark A. Emalfarb</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:21.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:2.25pt;margin-right:0pt;margin-top:0pt;text-align:left;"><b>Name:</b></div>
			</td>
			<td style="vertical-align:bottom;border-bottom: 1px #000000;;width:79.9%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:2.25pt;margin-right:0pt;margin-top:0pt;text-align:left;">Mark A. Emalfarb</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:21.5%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:2.25pt;margin-right:0pt;margin-top:0pt;text-align:left;"><b>Title:</b></div>
			</td>
			<td style="vertical-align:bottom;width:79.9%;">
			<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:2.25pt;margin-right:0pt;margin-top:0pt;text-align:left;">Chief Executive Officer</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&#xa0;</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex_336879.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html><head>
	<title>ex_336879.htm</title>
	<!-- Generated by ThunderDome Portal - 5/11/2022 1:21:14 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<div contenteditable="false" data-applyto="t" data-auto-pgnum="start" data-displaynum="1" data-fontname="Times New Roman" data-fontsize="10pt" data-numstyle="a" data-prefix="Page " data-startnum="1" data-suffix=" of 14" data-textalign="right">&nbsp;</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><i>Exhibit 10.1</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:25%;margin-left:0pt;margin-right:auto;">

		<tr>
			<td style="border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0); vertical-align: top; width: 217.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>Confidential</b></p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><i>Execution Version</i></b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt 0pt 0pt 8pt;"><b><i>Confidential</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 27pt;"><i>Portions of this Exhibit have been redacted because they are both (i) not material and (ii) would be competitively harmful if publicly disclosed. Information that was omitted has been noted in this document with a placeholder identified by the mark</i>&nbsp;"<i>[***]</i>&#8221;<i>.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><u>JOINT DEVELOPMENT AGREEMENT</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 27pt;">This Joint Development Agreement (the &#8220;<u>Agreement</u>&#8221; or &#8220;<u>JDA</u>&#8221;) is dated<b> </b>as of <font style="background-color:#ffff00;">May 12, </font>2022<b> </b>(&#8220;<u>Effective Date</u>&#8221;) by and between:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 45pt;">DYADIC INTERNATIONAL (USA) INC., (&#8220;<u>Dyadic</u>&#8221;) with its corporate headquarters at140 Intracoastal Pointe Drive, Suite 404 Jupiter, FL 33477</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 63pt;">and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 45pt;">LEPRINO FOODS COMPANY (and its subsidiaries and affiliates, only for so long as the same remain subsidiaries and affiliates, collectively, &#8220;<u>Leprino</u>&#8221; or &#8220;<u>LFC</u>&#8221;) with its corporate headquarters at 1830 West 38th Avenue, Denver, Colorado 80211, USA.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 27pt;">Dyadic and Leprino may be referred to collectively as the &#8220;<u>Parties</u>&#8221; and each separately as a &#8220;<u>Party</u>.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><u>RECITALS</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">A.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Dyadic is an R&amp;D-focused microbial biotechnology company that collaborates with market&#8209;leading companies to develop and commercialize novel strains and innovative production processes. Activities of Dyadic include strain engineering, engineering of biosynthetic pathways, media optimization, bioprocess development, impurity profile optimization and isolation of target materials.</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="text-align: justify; margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">B.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Leprino is [***]&nbsp;and a global leader in the production and sale of [***]dairy products. Leprino is interested in collaborating with Dyadic on development of complete technology for biotechnological production of [***] different [***]&nbsp;(the &#8220;Target [***]&#8221;&nbsp;defined below). The collaboration includes development and optimization of production strains, development of efficient upstream and downstream processing suitable for commercial production of the Target [***] in the microbial host which are identical in genetic sequence, [***]&nbsp;and [***] to [***] and can be used for commercial production [***].</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="text-align: justify; margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">C.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Dyadic and Leprino wish to enter an arrangement for this type joint development.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><u>AGREEMENT</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 27pt;">NOW THEREFORE, in consideration of the Party&#8217;s respective promises and obligations set forth below, the sufficiency and adequacy of which are hereby the Parties agree as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">1.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">DEFINITIONS</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 54pt;">Capitalized terms when used herein have shall have the meanings listed below or as defined elsewhere in this Agreement:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">1.1</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<u>Commercial Sale</u>&#8221;&nbsp;means (a) the sale of &#8220;[***]&#8221;&nbsp;(defined below) by Leprino to a third party or (b) internal transfer of [***]&nbsp;by Leprino for use in product [***]&nbsp;that will be sold to a third party (excluding the supply or transfer of samples for no or nominal consideration or any comparable transaction).</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="1" data-prefix="Page " data-suffix=" of 14" style="text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Page 1 of 14</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">1.2</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<u>Confidential Information</u>&#8221;&nbsp;means all non-public information and materials disclosed by a Party or Party affiliate (the &#8220;<u>Disclosing Party</u>&#8221;) to the other Party or Party affiliate (the &#8220;<u>Receiving Party</u>&#8221;) for the purposes of the Project (but not otherwise), relating to the Disclosing Party&#8217;s Pre-Existing Technology, Intellectual Property, business, finances, marketing, customers, suppliers, distribution, sales, programs, plans, and efforts, Proprietary Information and Trade Secrets. The JDA and any schedules and appendices hereto (the &#8220;<u>Scope of Work and (or) Project Schedule</u>&#8221;) drafted pursuant to the terms of this JDA, are also deemed to be Confidential Information. &#8220;Confidential Information&#8221;&nbsp;does not include information which (i) is or becomes generally available to the public other than as a result of a breach of this Agreement; (ii) at the time of disclosure to Receiving Party by Disclosing Party was already known by Receiving Party as evidenced by its written records; (iii) becomes available to a Party or Party affiliate on a non-confidential basis from a source that is entitled to disclose it on a non-confidential basis; (iv) is required to be disclosed by applicable laws or regulations (but in such event, only to the extent required to be disclosed); or (v) was or is independently developed by or for a Party or Party affiliate without reference to the Confidential Information, as evidenced by such Party&#8217;s, or Party affiliate&#8217;s, written records.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">1.3</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;[***].</p>
			</td>
		</tr>

</table>

<p style="text-align: justify; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">1.4</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<u>Direct Competitor</u>&#8221;&nbsp;means a company which: (a) utilizes or produces [***] for a functional or nutritional benefit, or (b) [***] to produce a [***] product other than [***].</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">1.5</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<u>Dyadic Platform Technology</u>&#8221;&nbsp;means any Intellectual Property, Proprietary Information, Confidential Information and/or Trade Secret comprising or related to Dyadic&#8217;s pre-existing and/or genetic elements, synthetic biology tools and strains as potential homologous and/or heterologous [***] expression hosts, as well all enhancements, improvements, developments, or other modifications to any of the foregoing which Dyadic invents, conceives, develops or derives in respect of the Project in the performance of the Agreement. For purposes of this definition, &#8220;pre-existing&#8221;&nbsp;means prior to the Effective Date. Provided, however, that subject to Leprino&#8217;s completion of all Phases of the Project and commencement of Commercial Sales, Dyadic Technology does not include the specific cell lines expressing the [***] which are developed and optimized within the Project (***] for commercial scale production, and which are used in the production of [***]&nbsp;using the host strain(s), which shall constitute Leprino Technology pursuant to Section 1.9 below.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">1.6</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<u>Goal or Deliverable</u>&#8221;&nbsp;means the goals and deliverables defined at <u>Schedule 1</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">1.7</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<u>Intellectual Property</u>&#8221;&nbsp;means all (a) copyrights (including the right to reproduce, distribute copies of, display, and perform the copyrighted work and to prepare derivative works), copyright registrations and applications, patent rights, patent applications and issuances, mask-work rights, Trade Secrets, Confidential Information, know-how, moral rights, author&#8217;s rights, privacy rights, publicity rights, algorithms, rights in packaging, goodwill, and other proprietary rights, and all renewals and extensions thereof; (b) intangible legal rights or interests evidenced by or embodied in or associated with any technology, idea, design, concept, technique, invention, discovery, enhancement or improvement, or Proprietary Information, whether or not patentable or copyrightable; and (c) all derivatives of any of the foregoing. For clarity, rights in and to trademarks and similar indicia of source or ownership are not within the scope of this Agreement and are therefore excluded from the definition of Intellectual Property.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="2" data-prefix="Page " data-suffix=" of 14" style="margin: 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Page 2 of 14</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="margin: 0pt;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">1.8</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<u>Jointly Developed Technology</u>&#8221;&nbsp;means any technology developed pursuant to this Agreement where each Party makes a non-financial contribution to a technical advancement which improves production yields of the [***]&nbsp;but excluding Dyadic Platform Technology and Leprino Technology.&nbsp;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">1.9</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<u>Leprino Technology</u>&#8221;&nbsp;means any Intellectual Property, Proprietary Information, Confidential Information and/or Trade Secret that is invented, conceived, developed or derived in respect of the Project in the performance of the Agreement by either Dyadic or Leprino resulting from either Party&#8217;s efforts, including (subject to Leprino&#8217;s completion of all Phases of the Project and commencement of Commercial Sales) the specific cell lines expressing the [***]&nbsp;which are developed and optimized within the Project ([***]) for commercial scale production, and which are used in the production of [***]&nbsp;using the host strain(s), but in all cases excluding Dyadic Platform Technology.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">1.10</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<u>Project Phase</u>&#8221;&nbsp;or &#8220;<u>Phase</u>&#8221;&nbsp;means the phase(s) defined at <u>Schedule 1</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">1.11</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<u>Pre-Existing Technology</u>&#8221;&nbsp;means any Intellectual Property, Proprietary Information, Confidential Information and/or Trade Secret, including but not limited to manufacturing, process and ingredient technology, that was rightfully in the possession of, invented, conceived, developed, owned or created by or licensed to or by a Party prior to the Effective Date of this Agreement.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">1.12</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<u>Project</u>&#8221;&nbsp;means the commercial research and development described in this JDA, the Scope of Work and Project Schedule at <u>Schedule 1</u>, and Dyadic&#8217;s proposal at <u>Appendix A</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">1.13</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<u>Project Steering Committee</u>&#8221;&nbsp;shall have the meaning set forth in Section 3.2.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">1.14</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<u>Proprietary Information</u>&#8221;&nbsp;means all non-public technical, business, financial and commercial information, samples, manufacturing processes, formulas, recipes, know-how, test results, ingredient, material and manufacturing specifications, all manuals, drawings, plans, designs and other documents, ideas, concepts and reports of a Party that are communicated to the other Party to the Agreement, whether such communication is made orally or in writing, and which may or may not be marked or specified orally as &#8220;confidential&#8221;&nbsp;or &#8220;Confidential Information,&#8221;&nbsp;or information or materials, owned, developed, or possessed by a Party protectable by law to the benefit of such Party including the laws of patents, copyrights, and Trade Secrets.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">1.15</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;[***]&#8221;&nbsp;or &#8220;<u>Target Molecules</u>&#8221;&nbsp;means [***], each matching [***], genetic sequences, [***] as deemed important by Leprino and other relevant specifications provided by Leprino in writing as of the Effective Date or as modified or updated by mutual written agreement of Dyadic and Leprino during the research and development phases of the Project.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">1.16</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#8220;<u>Trade Secret</u>&#8221;&nbsp;means information that is a Trade Secret as defined under the Delaware Uniform Trade Secrets Act, as amended from time to time, or under the comparable statutory or common law of any other U.S. state. Provided, however, where the definition of Trade Secret under the law of another state conflicts with the Delaware statutory definition, Delaware law will control.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="text-align: justify; margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">2.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">PROJECT DESCRIPTION; SCHEDULE; COSTS</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">2.1</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Project Description</u>. Dyadic shall be responsible for the research and development to use commercially reasonable efforts to achieve an economically feasible and commercially scalable fermentation process to support strain expression of the [***]. Leprino shall provide direction as to the importance of [***]. Leprino shall also conduct analytical and product development of [***].&nbsp;&nbsp;Leprino will keep Dyadic regularly informed all of these efforts and outcomes.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="3" data-prefix="Page " data-suffix=" of 14" style="margin: 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Page 3 of 14</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="margin: 0pt;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">2.2</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Scope of Work; Project Schedule</u>. Dyadic shall perform all research and development work described in its proposal attached <u>Appendix A</u>, and provide or procure all resources (<i>e.g.</i>, laboratory space, equipment, ingredients, product, personnel) and work required to take commercially reasonable efforts to meet the agreed upon Goals and Deliverables pursuant to the Scope of Work and Project Schedule as described in <u>Schedule 1</u>. Dyadic shall begin this work [***]. In the case the Project is terminated by Leprino, then Leprino agrees to destroy all of the genetic materials, including but not limited to the strains and all copies (<i>i.e.</i>, progeny) or descendants of such strains that are generated.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">2.3</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Fees; Project Costs</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">a.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Service Fees</u>. Leprino shall pay the amounts identified in <u>Schedule 1</u>&nbsp;for research and development work completed by Dyadic during a Project Phase as provided in <u>Schedule 1</u>. [***].</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">b.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Success Fees</u>. Leprino shall pay Dyadic the Success Fees identified in <u>Schedule 1</u>&nbsp;following written notification by Dyadic to Leprino of Dyadic&#8217;s, and Leprino&#8217;s confirmation of, completion and achievement of the applicable Goal or Deliverable.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">c.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Commercialization Fee</u>. Leprino shall pay Dyadic a Commercialization Fee in the amount stated in <u>Schedule 1</u>&nbsp;for timely completion and achievement of the Commercial Goal or Deliverable as defined in <u>Schedule 1, </u>following notification by Dyadic to Leprino, and Leprino&#8217;s confirmation of, such completion and achievement.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">d.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Royalties</u>. Leprino shall pay Dyadic a royalty fee of [***] of the value of the [***] sold commercially by Leprino within 30 days of the end of each quarter for a period of [***] years following the first Commercial Sale (the &#8220;Royalty Period&#8221;). &#8220;Value&#8221;&nbsp;shall be calculated as the monthly average of the [***].</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 90pt; text-align: justify;">Example:&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 81pt; text-align: justify;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">[***].</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 81pt; text-align: justify;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">[***].&nbsp;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 81pt; text-align: justify;">&nbsp;</td>
			<td style="width: 36pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">[***].&nbsp;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 81pt; text-align: justify;">The quantity of [***]sold shall be determined based on their [***].&nbsp;&nbsp;Upon written request by Dyadic and not more than once per year, Leprino shall retain an independent agency (to which Dyadic has no reasonable objection) to verify the quantity of [***] produced for commercial sale or internal transfer.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 81pt; text-align: justify;">In no event shall the total amount of royalties due by Leprino be less than [***] per year.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">e.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Project Costs and Expense</u>. [***].</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">f.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Except as expressly stated elsewhere in this Agreement (including Schedules and Exhibits), payments shall be due net [***] of receipt of invoice.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="4" data-prefix="Page " data-suffix=" of 14" style="text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Page 4 of 14</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">3.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">PROJECT MANAGERS</p>
			</td>
		</tr>

</table>

<p style="text-align: justify; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">3.1</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Project Managers</u>. Dyadic and Leprino will each name one of its employees as the primary point of contact for the other Party for the Scope of Work and Project Schedule (each, a &#8220;<u>Project Manager</u>&#8221;). The Parties&#8217;&nbsp;respective Project Managers shall [***]. The Project Managers shall be responsible for developing and managing the Scope of Work and Project Schedule and shall jointly review them periodically to determine whether any changes are appropriate and to provide periodic summaries of the scope of completed and ongoing or uncompleted Project activities and efforts, as well as any proposed changes in the Scope of Work or Project Schedule to Project Steering Committee.</p>
			</td>
		</tr>

</table>

<p style="text-align: justify; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">3.2</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Project Steering Committee</u>. Each Party [***]&nbsp;the &#8220;Project Steering Committee.&#8221;&nbsp;Of the employees selected by each Party, one employee shall be a technically qualified management-level research and development employee and the other employee shall be a [***]. The Project Steering Committee shall meet, [***] to review Project status, consider and make decisions regarding changes to the Project, Scope of Work or Project Schedule proposed by one or more Project Managers and/or Project Steering Committee members, and provide guidance to the Project Managers regarding future Project activities and efforts. Minutes of Project Steering Committee meetings and teleconferences shall be: ([***]. When necessary or expedient, these time periods may be extended or shortened by the Project Steering Committee</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="text-align: justify; margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">4.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">INTELLECTUAL PROPERTY; LICENSES</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">4.1</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Pre-Existing Technology</u>. Each Party shall solely and exclusively own and retain all Intellectual Property rights to its respective Pre-Existing Technology, subject to any license that is granted under this Agreement.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">4.2</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Dyadic Platform Technology</u>. Dyadic shall retain sole and exclusive ownership of all Intellectual Property rights to Dyadic Platform Technology without any limitation for further commercialization, except as may be limited by licenses to Leprino described below [***]</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Symbol;font-size:10pt;">

		<tr>
			<td style="width: 59pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">a.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: Symbol; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">[***]&nbsp;or</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Symbol;font-size:10pt;">

		<tr>
			<td style="width: 59pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">b.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: Symbol; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">[***],</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Symbol; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 59pt; text-align: justify;">[***].</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">4.3</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Leprino Technology</u>. Leprino shall have sole and exclusive ownership of all Intellectual Property rights to Leprino Technology.</p>
			</td>
		</tr>

</table>

<p style="text-align: justify; margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">4.4</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Jointly Developed Technology</u>. The Parties shall jointly own Jointly Developed Technology [***].</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">4.5</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Platform Technology Licenses</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Symbol;font-size:10pt;">

		<tr>
			<td style="width: 59pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">a.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Research and Development License</u>. In consideration of Leprino&#8217;s payment of Service Fees and its other Project obligations, Dyadic shall grant Leprino a license to utilize Dyadic Platform Technology for production of [***] during the research and development Phases of the Project and in accordance with Scope of Work and Project Schedule.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Symbol;font-size:10pt;">

		<tr>
			<td style="width: 59pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">b.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Commercial License</u>. In consideration of and subject to Leprino&#8217;s payment of the Commercialization Fee and Royalties, Dyadic shall grant Leprino a [***] license to utilize the [***] developed during the research and development Phases of the Project solely for purposes of producing the [***] for inclusion in [***]. From and after the earlier of (i) completion of the Project and (ii) Commercial Sale, Leprino shall use commercially reasonable efforts to commercially exploit the Target [***] hereunder and maximize the value therefrom. On an annual basis during the Term, Leprino shall provide Dyadic with a summary of Leprino&#8217;s significant commercialization activities with respect to [***] since the last such report.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="5" data-prefix="Page " data-suffix=" of 14" style="text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Page 5 of 14</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Symbol;font-size:10pt;">

		<tr>
			<td style="width:59pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">c.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>No Implied Licenses</u>. Except as explicitly set forth in this Agreement, neither Party shall be deemed by estoppel or implication to have granted the other Party any license or other right to any Intellectual Property of such Party. All rights not otherwise expressly granted hereunder by a Party shall be retained.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">4.6</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Patent Protection</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt; text-align: justify;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">a.</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">[***].</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt; text-align: justify;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">b.</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">Patent protection for Jointly Developed Technology requires the full consent and mutual agreement of both Parties with respect patent claims, individual inventors, ownership, and responsibility for filing, prosecuting and maintaining and the associated costs.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 54pt; text-align: justify;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">c.</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-align: justify;">For the avoidance of doubt, the Parties agree that: (i) Leprino may not seek a patent which is based on or claims Dyadic Platform Technology; and (ii) Dyadic may not seek a patent which is based on or claims Leprino Technology.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="text-align: justify; margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">5.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">WARRANTY OF NON-INFRINGEMENT; INDEMNITY</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">5.1</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Non-Infringement Warranty</u>. Each Party represents and warrants as follows:</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Symbol;font-size:10pt;">

		<tr>
			<td style="width: 54pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">a.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: Symbol; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">[***].</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Symbol;font-size:10pt;">

		<tr>
			<td style="width: 54pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">b.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: Symbol; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">[***].</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Symbol;font-size:10pt;">

		<tr>
			<td style="width: 54pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">c.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: Symbol; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">[***].</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Symbol;font-size:10pt;">

		<tr>
			<td style="width: 54pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">d.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: Symbol; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">[***].</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: Symbol; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">5.2</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Symbol; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">[***] agrees to indemnify and hold the receiving Party harmless from and against all claims, losses, expenses (including reasonable attorneys&#8217;&nbsp;fees, consultant and expert fees), damages or liabilities (hereafter, &#8220;Claims&#8221;) arising out of, based on or related to any alleged, claimed, incurred, or proven claim by any third party relating to, based on or arising out of breach of the representation and warranty in Section 5.1.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="text-align: justify; margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">6.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Symbol; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>[***]</b>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: Symbol; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">6.1</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Symbol; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">[***]</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: Symbol; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">6.2</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Symbol; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">[***].</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: Symbol; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">6.3</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Symbol; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">[***].</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: Symbol; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">6.4</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Symbol; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">[***].</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="text-align: justify; margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">7.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">CONFIDENTIALITY</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">7.1</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Confidentiality Agreement between the Parties dated [***], shall continue in full force and effect during the Term and shall govern the Parties&#8217;&nbsp;obligations of confidentiality relating to this Agreement and all other matters; however, the Purpose (as defined therein) shall be amended to include each Party&#8217;s conduct of its activities required or authorized under this Agreement, including the performance of the Project. A copy of the Confidentiality Agreement is attached at <u>Appendix B.</u></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="6" data-prefix="Page " data-suffix=" of 14" style="margin: 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Page 6 of 14</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="margin: 0pt;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">7.2</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">For the avoidance of doubt and to the extent not covered by the Confidentiality Agreement, neither Party will make any public disclosure concerning this Agreement, their discussions or any other matter relating to the potential Project, unless the other Party expressly consents in writing and subject to that Party&#8217;s review and approval of the language and content of the disclosure; provided, however, Dyadic will have the right&nbsp;under its obligations as a&nbsp;publicly traded&nbsp;company&nbsp;to include information&nbsp;about the Project&nbsp;required to under its public disclosure obligations with NASDAQ and the SEC, but such&nbsp;disclosure(s) shall be limited to the minimum information required by law (as determined by Dyadic&#8217;s outside law firm). Each Party expressly acknowledges in this Agreement as of the Effective Date that it is not a legal requirement to issue a press release concerning the two parties entering into this Agreement, however, Leprino and Dyadic shall mutually agree on the content of any public statements reasonably necessary in conjunction with Dyadic's requirement under its public disclosure obligations with NASDAQ and the SEC, but such disclosure(s) shall be limited to the minimum information required by law (as determined by Dyadic&#8217;s outside law firm). Neither Party shall directly or indirectly use any of the other Party&#8217;s technology, business plans or other information for a similar or competitive Project. The terms and conditions of this Agreement, the fact that the Project is taking place, and the status and results thereof will also be held in confidence by both Parties and not disclosed to any third party (other than a Party's representatives who have a need to know such information, and provided that the representatives have executed a confidentiality agreement acknowledging their confidentiality obligations) or as provided in this Section</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="text-align: justify; margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">8.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">TERM; PROJECT END DATE; TERMINATION</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">8.1</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Term</u>. This Agreement takes effect on the Effective Date and, unless terminated earlier as provided in Section 2.2 or this Section 8, the Agreement shall expire at the end of the Royalty Period (the &#8220;<u>Term</u>&#8221;); provided however, that the Commercial License described at Section 4.5.b above shall remain in effect indefinitely after the Royalty Period expires (but, for clarity, not in the event of a termination under Section 2.2, 8.2 or 11.1).</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">8.2</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Termination</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Symbol;font-size:10pt;">

		<tr>
			<td style="width: 59pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">a.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Dyadic or Leprino may terminate this Agreement for cause, in whole or in part, as of the date specified in a notice of termination, in the event of a material breach of this Agreement by the other Party (whether in a single breach or a series of breaches that are collectively material) and the Party in breach does not cure the breach giving rise to the right to terminate within [***] business days after receipt of such notice.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Symbol;font-size:10pt;">

		<tr>
			<td style="width: 59pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">b.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Except as provided in Section 2.2, 11.1, or this Section 8.2, this Agreement may only be terminated by mutual written consent signed by both Parties&#8217;&nbsp;representatives.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="text-align: justify; margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">9.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">REPRESENTATIONS AND WARRANTIES</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">9.1</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Each Party represents and warrants to, and agrees with the other Party that:</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Symbol;font-size:10pt;">

		<tr>
			<td style="width: 59pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">a.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">It has and will continue to have full power and authority to enter into this Agreement, and to perform its obligations under this Agreement fully, and no agreement or understanding with any third party exists or will exist that would interfere with those obligations.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="7" data-prefix="Page " data-suffix=" of 14" style="margin: 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Page 7 of 14</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="margin: 0pt;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Symbol;font-size:10pt;">

		<tr>
			<td style="width:59pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">b.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In the case of Leprino, only a Leprino representative will sign this Agreement including any changes, extensions, or renewals of this Agreement; and, in the case of Dyadic, only a Dyadic representative will sign this Agreement including any changes, extensions, or renewals of this Agreement.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Symbol;font-size:10pt;">

		<tr>
			<td style="width: 59pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">c.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Each Party will comply with all applicable U.S. federal, U.S. state, and local laws, rules, regulations, and orders promulgated by any governmental agency having jurisdiction over it that are applicable in performing its obligations under this Agreement, as well as the laws of any non-U.S. country, state, province, or locality in which any work contemplated by this Agreement is performed.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Symbol;font-size:10pt;">

		<tr>
			<td style="width: 59pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">d.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Each Party represents and warrants that it has or will obtain all licenses, permits, and authority required to perform its respective obligations under this Agreement.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">9.2</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">EXCEPT AS EXPRESSLY STATED IN THIS AGREEMENT, NO REPRESENTATIONS OR WARRANTIES WHATSOEVER, ARE MADE OR GIVEN BY OR ON BEHALF OF A PARTY, AND ALL REPRESENTATIONS AND WARRANTIES, WHETHER ARISING BY OPERATION OF LAW OR OTHERWISE, ARE HEREBY EXPRESSLY EXCLUDED.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">9.3</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">NEITHER PARTY SHALL BE LIABLE TO THE OTHER FOR ANY SPECIAL, CONSEQUENTIAL, INCIDENTAL, PUNITIVE, OR INDIRECT DAMAGES ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT, REGARDLESS OF ANY NOTICE OF THE POSSIBILITY OF SUCH DAMAGES. [***].</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; vertical-align: top;">
			<p style="text-align: justify; margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">10.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">INDEPENDENT CONTRACTORS</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">10.1</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Nothing in this Agreement will be construed as making any of the Parties or any of their affiliates the partner, joint venture participant, agent, employer, or employee of any of the other Parties. No Party or any of its affiliates will have the authority to make any statements, representations, nor commitments of any kind, or to take any action which will be binding on the other Party, except as provided for herein or authorized in writing by the Party to be bound.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="text-align: justify; margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">11.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">FORCE MAJEURE</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">11.1</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Each Party to this Agreement shall be excused from any performance required under this Agreement (to the extent affected) if such performance is rendered impossible due to any act of God, fire, riot, civil commotion, act of public enemy, act of terror or terrorism, epidemic, pandemic, weather, war, insurrection, embargos, government restrictions and/or catastrophe (a &#8220;<u>Force Majeure Event</u>&#8221;) and the affected Party notifies the other Party in writing of the circumstances which give rise to the protections of this Section 11.1. When such Force Majeure Event has abated, the obligations of the Party who invoked such protections shall resume. The timing for any obligations under this Agreement of a Party experiencing a Force Majeure Event shall be extended by the amount of delay caused by the Force Majeure Event. In the event such Force Majeure Event continues for [***], the Party awaiting performance may terminate this Agreement upon receipt of written notice to the non-performing Party.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="text-align: justify; margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">12.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">NOTICES</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">12.1</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">All notices under this Agreement must be in writing and will be considered received on: (a) the date of personal or courier delivery, or [***].</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="8" data-prefix="Page " data-suffix=" of 14" style="text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Page 8 of 14</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Symbol;font-size:10pt;width:74.7058823529412%;margin-left:0pt;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:38.4%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 72pt;"><u>If to Dyadic</u>:</p>
			</td>
			<td style="vertical-align:top;width:47.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">[***]</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:38.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:47.1%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:38.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:47.1%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:38.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><u>With a copy to</u>:&nbsp; &nbsp; &nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:47.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">[***]</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:38.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:47.1%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:38.4%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 72pt;"><u>If to Leprino:</u>&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:47.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">[***]</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:38.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:47.1%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:38.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:47.1%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:38.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><u>With a copy to</u>:&nbsp; &nbsp; &nbsp;&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:47.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">[***]</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:38.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:47.1%;">&nbsp;</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">13.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">MISCELLANEOUS</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">13.1</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Assignment; Successors and Assigns</u>. No Party to this Agreement may assign or transfer this Agreement or any part of this Agreement or its rights or obligations in whole or part under this Agreement without the other Party&#8217;s prior written approval, except that a Party may make such an assignment or transfer without the other Party&#8217;s consent to (a) its affiliates, or (b) subject to Section 4.2 above, a third party successor to all or substantially all of the business of such Party to which this Agreement relates, whether in a merger, sale of stock, sale of assets or other change of control transaction; otherwise, any purported assignment or transfer without such approval is void and shall have no force or effect. Any successor or assignee of rights and/or obligations permitted hereunder shall, in writing to the other Party, expressly assume performance of such rights and/or obligations. Any permitted assignment shall be binding on the successors of the assigning Party.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">13.2</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Entire Agreement; Conflicts</u>. This Agreement, all exhibits attached hereto and any Scope of Work and Project Schedule to which the Parties may later agree (all of which are incorporated herein) constitute the entire agreement between the Parties pertaining to the subject matter contained herein and supersede all prior and contemporaneous agreements, representations and understandings of any kind or nature; provided, however, that in the event of any express conflict between the terms and provisions of any exhibit, schedule or rider and the terms and provisions of this Agreement, the terms and provisions of this document shall control. Notwithstanding this Section 13.2, in the event of any conflict between this Agreement and the Mutual Confidentiality Agreement, this Agreement shall control in all respects.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">13.3</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Amendments</u>. No changes, extensions, or renewals to this Agreement or any assurance, statement or representation shall be binding unless executed in writing by an authorized representative of each Party.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">13.4</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Severability</u>. In the event that one or more of the provisions contained in this Agreement will be invalid, illegal or unenforceable in any respect, the validity, legality, and enforceability of the remaining provisions contained herein will not in any way be affected or impaired. In such event, such provision or provisions will be validly reformed to approximate the intent of the Parties as nearly as possible and, if not reformable, will be severed and deleted from this Agreement.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">13.5</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Governing Law; Jurisdiction; Dispute Resolution</u>.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Symbol;font-size:10pt;">

		<tr>
			<td style="width: 59pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">a.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">This Agreement and all questions relating to the validity, interpretation, rights, and remedies of all Parties under this Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware applicable to contracts made and performed in such state (without regard to principles of conflicts of laws).</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="9" data-prefix="Page " data-suffix=" of 14" style="margin: 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Page 9 of 14</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="margin: 0pt;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Symbol;font-size:10pt;">

		<tr>
			<td style="width:59pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">b.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Any legal action arising from or related to this Agreement shall be field in the United States District Court for the District of Delaware. The prevailing party in any legal proceeding arising from or related to this Agreement shall be entitled to recover its reasonable attorneys&#8217;&nbsp;fees and other reasonable litigation costs and expense from the non-prevailing party.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Symbol;font-size:10pt;">

		<tr>
			<td style="width: 59pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">c.</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The prevailing party in any arbitration or any legal action in a court of law shall be entitled to an award of its attorneys' fees.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">13.6</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>No Waiver</u>. The failure of any Party to enforce any of the provisions of this Agreement will not be construed as a waiver of those provisions, will not affect the validity of any part of this Agreement and will not affect the right of any Party to thereafter enforce each and every provision. All remedies afforded to any of the Parties in this Agreement will be taken and construed as cumulative, that is, in addition to every other remedy provided at law or in equity.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt; text-align: justify;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">13.7</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Headings; Interpretation</u>. The captions in this Agreement are for convenience only and will not be considered a part of or affect the construction or interpretation of any provision hereof. The use of the terms &#8220;including&#8221;&nbsp;or &#8220;include&#8221;&nbsp;shall in all cases herein mean &#8220;including, without limitation&#8221;&nbsp;or &#8220;include, without limitation,&#8221;&nbsp;respectively; &#8220;$&#8221;&nbsp;means U.S. dollars; &#8220;&#8364;&#8221;&nbsp;means Euros; and &#8220;affiliate&#8221;&nbsp;means, with respect to a person or entity, any other person or entity controlling, controlled by or under common control with the first, for so long as such control exists and &#8220;control&#8221;&nbsp;means (a) direct or indirect ownership of fifty percent (50%) or more of the stock or shares having the right to vote for the election of directors of such person or entity or (b) the possession, directly or indirectly, of the power to direct, or cause the direction of, the management or policies of such person or entity by ownership, contract or otherwise.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="text-align: justify; margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">13.8</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><u>Survival</u>. Except as otherwise provided in this Agreement, each Party&#8217;s rights and obligations that accrued before the date of any permitted termination or expiration shall survive the expiration and termination of this Agreement. For the avoidance of doubt, the perpetual Commercial License described at Section 4.5.b shall remain in effect indefinitely after the Royalty Period expires (but, for clarity, not in the event of a termination under Section 2.2, 8.2 or 11.1). All rights and obligations that do not expressly survive shall terminate upon the expiration or termination of this Agreement for any reason.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">AGREED AND ACCEPTED</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Symbol;font-size:10pt;width:74.7058823529412%;margin-left:0pt;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:51.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">DYADIC INTERNATIONAL (USA) INC.</p>
			</td>
			<td style="vertical-align:top;width:51.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">LEPRINO FOODS COMPANY</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:51.1%;">&nbsp;</td>
			<td style="vertical-align:top;width:51.2%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:51.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">BY:&nbsp;<u> &nbsp;&nbsp;/s/ Mark Emalfarb&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</u></p>
			</td>
			<td style="vertical-align:top;width:51.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">BY:<u>&nbsp;/s/ Mike Durkin&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</u></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:51.1%;">&nbsp;</td>
			<td style="vertical-align:top;width:51.2%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:51.1%;">&nbsp;</td>
			<td style="vertical-align:top;width:51.2%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:51.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Name:&nbsp;<u> &nbsp; &nbsp;&nbsp;Mark Emalfarb&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</u></p>
			</td>
			<td style="vertical-align:top;width:51.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Name: <u>Mike Durkin&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</u></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:51.1%;">&nbsp;</td>
			<td style="vertical-align:top;width:51.2%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:51.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Title:&nbsp;<u> &nbsp; &nbsp; &nbsp;&nbsp;CEO&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</u></p>
			</td>
			<td style="vertical-align:top;width:51.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Title:&nbsp;<u> &nbsp;&nbsp;President&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</u></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:51.1%;">&nbsp;</td>
			<td style="vertical-align:top;width:51.2%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 51.1%; text-align: center;">5/10/2022</td>
			<td style="vertical-align: top; width: 51.2%; text-align: center;">5/10/2022</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="10" data-prefix="Page " data-suffix=" of 14" style="text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Page 10 of 14</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><u>SCHEDULE 1</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">[***]</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="11" data-prefix="Page " data-suffix=" of 14" style="text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Page 11 of 14</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><u>APPENDIX A</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">[***]</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" data-number="12" data-prefix="Page " data-suffix=" of 14" style="text-align: right; width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Page 12 of 14</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><u>APPENDIX B</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">[***]</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="13" data-prefix="Page " data-suffix=" of 14" style="text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Page 13 of 14</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><u>APPENDIX C</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><u>PRESS RELEASE</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>See EX-99.1</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="14" data-prefix="Page " data-suffix=" of 14" style="text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">Page 14 of 14</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ex_336880.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head>
	<title>ex_336880.htm</title>
	<!-- Generated by ThunderDome Portal - 5/11/2022 12:37:19 AM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt 0pt 0pt 8pt;"><b>Exhibit 99.1</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><img alt="ex_316856img001.jpg" src="ex_316856img001.jpg" style="width:111;height:80;"></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 14pt; font-variant: normal; text-align: center; margin: 0pt 0pt 0pt 16pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 14pt; font-variant: normal; text-align: center; margin: 0pt 0pt 0pt 16pt;"><b>Dyadic Announces&nbsp;Research, License and Collaboration for the Manufacture of </b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 14pt; font-variant: normal; text-align: center; margin: 0pt 0pt 0pt 16pt;"><b>Animal Free Ingredients</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 14pt; font-variant: normal; text-align: center; margin: 0pt 0pt 0pt 16pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">JUPITER, FL / May<font style="background-color:#ffff00;"> 11</font>, 2022,&nbsp;Dyadic International, Inc. (&#8220;Dyadic&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221;, or the &#8220;Company&#8221;) (NASDAQ: DYAI),&nbsp;a global biotechnology company focused on further improving, applying, and deploying its proprietary protein production platform, today announced that it has entered into a Joint Development Agreement (&#8220;Agreement&#8221;) with a Global Food Ingredients Company to develop and manufacture a number of animal free ingredient products using the company&#8217;s biotechnologies.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Under the terms of the Agreement:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The research project will be fully funded by the Global Food Ingredients Company up to &#8364;3.6 million euros.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Dyadic to develop its proprietary production cell lines for the manufacture of animal free ingredient product candidates.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Dyadic will receive certain defined &#8220;Success Fees&#8221;, upon reaching certain productivity and activity levels and milestones at different stages of the collaboration.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Dyadic will receive a &#8220;Commercialization Fee&#8221;&nbsp;of low eight figures upon commercialization, and a royalty payment of low single digits based on commercial sales.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#8220;While our primary focus remains speeding the adoption of our C1 protein production platform for use in developing and manufacturing biopharmaceuticals, we believe that this strategic partnership demonstrates the company&#8217;s ability to leverage its technologies by taking advantage of emerging market opportunities to enhance the value the company can bring to biomanufacturing,&#8221; said Mark Emalfarb, Dyadic's President, and Chief Executive Officer.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>About Dyadic International, Inc. </b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Dyadic International, Inc. is a global biotechnology company which is developing what it believes will be a potentially significant biopharmaceutical gene expression platform based on the fungus&nbsp;<i>Thermothelomyces heterothallica</i> (formerly <i>Myceliophthora thermophila),</i> named C1. The C1 microorganism, which enables the development and large-scale manufacture of low-cost proteins, has the potential to be further developed into a safe and efficient expression system that may help speed up the development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales. Dyadic is using the C1 technology and other technologies to conduct research, development and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles (VLPs) and antigens, monoclonal antibodies, Fab antibody fragments, Fc-Fusion proteins, biosimilars and/or biobetters, and other therapeutic proteins. Certain other research activities are ongoing which include the exploration of using C1 and other technologies to develop and produce certain metabolites and other biologic products. Dyadic pursues research and development collaborations, licensing arrangements and other commercial opportunities with its partners and collaborators to leverage the value and benefits of these technologies in development and manufacture of biopharmaceuticals. As the aging population grows in developed and undeveloped countries, Dyadic believes the company&#8217;s technologies may help bring biologic vaccines, drugs, and other biologic products to market faster, in greater volumes, at lower cost, and with new properties to drug developers and manufacturers, and improve access and cost to patients and the healthcare system, but most importantly save lives.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Please visit Dyadic's website at&nbsp;https://www.dyadic.com&nbsp;for additional information, including details regarding Dyadic's plans for its biopharmaceutical business.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Safe Harbor Regarding Forward-Looking Statements</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including those regarding Dyadic International's expectations, intentions, strategies, and beliefs pertaining to future events or future financial performance. Actual events or results may differ materially from those in the forward-looking statements because of various important factors, including those described in the Company's most recent filings with the SEC. Dyadic assumes no obligation to update publicly any such forward-looking statements, whether because of new information, future events or otherwise. For a more complete description of the risks that could cause our actual results to differ from our current expectations, please see the section entitled "Risk Factors" in Dyadic's annual reports on Form 10-K and quarterly reports on Form 10-Q filed with the SEC, as such factors may be updated from time to time in Dyadic's periodic filings with the SEC, which are accessible on the SEC's website and at&nbsp;https://www.dyadic.com.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Contact:</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Dyadic International, Inc.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Ping W. Rawson</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Chief Financial Officer</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Phone: (561) 743-8333</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Email: ir@dyadic.com</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>dyai-20220510.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 5/11/2022 1:27:44 PM-->
<xsd:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:dyai="http://www.dyai.com/20220510" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.dyai.com/20220510">
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd"/>

<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dyai-20220510_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dyai-20220510_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dyai-20220510_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.dyai.com/20220510/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:presentationLink</link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="dyai_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>dyai-20220510_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 5/11/2022 1:27:44 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
<link:roleRef roleURI="http://www.dyai.com/20220510/role/statement-document-and-entity-information" xlink:href="dyai-20220510.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:definitionLink xlink:role="http://www.dyai.com/20220510/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>


<link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>dyai-20220510_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 5/11/2022 1:27:44 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
<link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Type</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Period End Date</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Registrant Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Incorporation, State or Country Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityFileNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, File Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Tax Identification Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line One</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, City or Town</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, State or Province</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Postal Zip Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:label xlink:label="dei_WrittenCommunications-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:label xlink:label="dei_SolicitingMaterial-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementIssuerTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Emerging Growth Company</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:label xlink:label="dei_Security12bTitle-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:label xlink:label="dei_TradingSymbol-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:label xlink:label="dei_SecurityExchangeName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Central Index Key</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>

</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>dyai-20220510_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 5/11/2022 1:27:44 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.dyai.com/20220510/role/statement-document-and-entity-information" xlink:href="dyai-20220510.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:presentationLink xlink:role="http://www.dyai.com/20220510/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>

<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>

<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ex_316856img001.jpg
<TEXT>
begin 644 ex_316856img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !0 &\# 2(  A$! Q$!_\0
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M_P"@K8?]\O\ X5[-IG_(+M/^N*?^@BK5:*E&QSO&UD]SP_\ X4IK7_05L/\
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I9_R"[3_KBG_H(JY4<4:0Q)&@PB*%4>@%25:V,&[L****!!1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140227918068360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>May 10, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity, Registrant Name</a></td>
<td class="text">Dyadic International, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document, Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document, Period End Date</a></td>
<td class="text">May 10,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity, Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity, File Number</a></td>
<td class="text">000-55264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity, Tax Identification Number</a></td>
<td class="text">45-0486747<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity, Address, Address Line One</a></td>
<td class="text">140 Intracoastal Pointe Drive, Suite 404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity, Address, City or Town</a></td>
<td class="text">Jupiter<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity, Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity, Address, Postal Zip Code</a></td>
<td class="text">33477<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">743-8333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity, Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DYAI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity, Central Index Key</a></td>
<td class="text">0001213809<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>dyai20220216_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="dyai-20220510.xsd" xlink:type="simple"/>
    <context id="d20228K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001213809</identifier>
        </entity>
        <period>
            <startDate>2022-05-10</startDate>
            <endDate>2022-05-10</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="d20228K">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d20228K">0001213809</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d20228K">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="d20228K">2022-05-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="d20228K">Dyadic International, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="d20228K">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="d20228K">000-55264</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="d20228K">45-0486747</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d20228K">140 Intracoastal Pointe Drive, Suite 404</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="d20228K">Jupiter</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d20228K">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d20228K">33477</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d20228K">561</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d20228K">743-8333</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="d20228K">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="d20228K">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="d20228K">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="d20228K">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="d20228K">false</dei:EntityEmergingGrowthCompany>
    <dei:Security12bTitle contextRef="d20228K">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d20228K">DYAI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d20228K">NASDAQ</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M*=8,87H8;+#\:+-@(F**?%FM+JP?KE=+5N8"#W?N'\BF6F= 5@N(R]8"ELG
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M:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    "  V3ZM4.JJBYT !   \ @
M#P   'AL+W=O<FMB;V]K+GAM;(U176O#, S\*\8_8$G+5EAI!F/=1V%L91U]
M=V*E$;6M8*OMUE\_)2&LL)<]R3J)T]UY<:*X+XGVZLN[D K=,+?S+$M5 ]ZD
M*VHAR*2FZ U+&W=9:B,8FQH ]BZ;YODL\P:#OEN,7.N873;$4#%2$+ #M@BG
M]#OO6G7$A"4ZY.]"]V\'6GD,Z/$,MM"Y5JFATPM%/%-@XS95).<*/1D&6XB,
MU1]XTXG\-&7J$3;EAQ$AA9[E0EAC3-QO]/Q&-!Y!EH?NP/2$CB$N#<-SI$.+
M8=?1B(OLPD:?PUB'$.?Q/S%276,%2ZH.'@(/.49PG<"0&FR35L%X*/2XHNZ#
M58^!)22U"@.5['9.Y?3*#JY9Y%YD&.<H@[BR@_!1K84: ]@W.9 $E^2J=51=
MZ7FFUS>36TGHX-R#8._AE8P=S8\?=_<#4$L#!!0    ( #9/JU0D'INBK0
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M;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ -D^K5 PA&HOO    *P(  !$
M             ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @
M-D^K5)E<G",0!@  G"<  !,              ( !S0$  'AL+W1H96UE+W1H
M96UE,2YX;6Q02P$"% ,4    "  V3ZM4^P$V_#8$  !C$   &
M    @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @
M-D^K5)^@&_"Q @  X@P   T              ( !>@P  'AL+W-T>6QE<RYX
M;6Q02P$"% ,4    "  V3ZM4EXJ[',     3 @  "P              @ %6
M#P  7W)E;',O+G)E;'-02P$"% ,4    "  V3ZM4.JJBYT !   \ @  #P
M            @ $_$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ -D^K
M5"0>FZ*M    ^ $  !H              ( !K!$  'AL+U]R96QS+W=O<FMB
M;V]K+GAM;"YR96QS4$L! A0#%     @ -D^K5&60>9(9 0  SP,  !,
M         ( !D1(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^
) @  VQ,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="dyai20220216_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dyai.com/20220510/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="dyai20220216_8k.htm">dyai20220216_8k.htm</File>
    <File>dyai-20220510.xsd</File>
    <File>dyai-20220510_def.xml</File>
    <File>dyai-20220510_lab.xml</File>
    <File>dyai-20220510_pre.xml</File>
    <File>ex_336879.htm</File>
    <File>ex_336880.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "dyai20220216_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "local": [
      "dyai-20220510_def.xml"
     ]
    },
    "inline": {
     "local": [
      "dyai20220216_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "dyai-20220510_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "dyai-20220510_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "dyai-20220510.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"
     ]
    }
   },
   "elementCount": 26,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "dyai",
   "nsuri": "http://www.dyai.com/20220510",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dyai20220216_8k.htm",
      "contextRef": "d20228K",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "role": "http://www.dyai.com/20220510/role/statement-document-and-entity-information",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dyai20220216_8k.htm",
      "contextRef": "d20228K",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dyai.com/20220510/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dyai.com/20220510/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dyai.com/20220510/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document, Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dyai.com/20220510/role/statement-document-and-entity-information"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document, Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dyai.com/20220510/role/statement-document-and-entity-information"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity, Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dyai.com/20220510/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity, Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dyai.com/20220510/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity, Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dyai.com/20220510/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity, Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dyai.com/20220510/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity, Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dyai.com/20220510/role/statement-document-and-entity-information"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dyai.com/20220510/role/statement-document-and-entity-information"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity, Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dyai.com/20220510/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity, File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dyai.com/20220510/role/statement-document-and-entity-information"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity, Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dyai.com/20220510/role/statement-document-and-entity-information"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity, Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dyai.com/20220510/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity, Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dyai.com/20220510/role/statement-document-and-entity-information"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dyai.com/20220510/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dyai.com/20220510/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dyai.com/20220510/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dyai.com/20220510/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dyai.com/20220510/role/statement-document-and-entity-information"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dyai.com/20220510/role/statement-document-and-entity-information"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dyai.com/20220510/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dyai.com/20220510/role/statement-document-and-entity-information"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.dyai.com/20220510/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001437749-22-011845-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-22-011845-xbrl.zip
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M#@L;^,AO]'_1)L/^_'"XKS[4?^O*._\#4$L#!!0    ( #9/JU1AB_41^P4
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M8CF'YR8=RU3,)(QNHE,<PAC^ID'!&^&CCGC0@SC()K"A0)PP(BE >@1J'(=
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M!EG:<-8PS 3:.BDCH)>L.M%--[!5%Y0]RS',"K?>!9C\H\Z&/B8$PE#0RZU
M18'K1Y04'V+\^5KJD#66V!XQ(A@^NZ!'11RB3I3)0G(N2]%/*(KMII@;(<><
M90BJ%ZT#\ :\QA)8EM K*J<<B:YZ+BF_4(;PDL%<?(SB681756^$:]0UKD[
MI(N9#[,$DQ(Q03( _F]H/# @-^O27->0.AXQ8AZ!OP%]:6"RPR2>P*\FSI)
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ML?@(*Z-2#T"<2Q]M6Z(TB4->+<Z=.>:+9MI0L1<"OR?3."',Z_4KS!OA&AW
ML+%UA-<QB7* HEAPDR7,,*( 8U.T(G_1" R;$)=HB/:\V:"F?^:X=@0'AMDZ
M?.#H30W?.VK#496DGQS)WV#@K]JNB&:R\L4\X.+MWK+DT;U*RI$IR-;N.]]4
M1\;J>$4Y7G&T7>4J()[:P-42Y9=N8^^74 >I68:[W! ,?#S6?>*UKL,7TG#*
MS2F0Z_3 L"!:_(#EE?BM:T/0P\NS4/D\LDB&1+& +#*QS2QV+*^U]9H)1DZ"
M&#F:=)P#>Z91JJ5.LU19)&::4P%TLJRA''  K&CSF(R3$K;S#')729TD;#HA
MMXS!V(L:*%H'EGAY$Y@)CBM2,793<.]>3(FDZTNX*Z6D2.2@D4Q7]8_AVKPJ
M<F:4]S>A5@6X?:5)%^TCZ)'&I5GPC;29('#<UF =/8:A\ER25;<OZSZQ]MI!
M'&0>J[4"#)6?%.50#D133B<Y0A3 97->,M>%9GQXTSL&!ES3U6AI#I.3K[;N
MT98OUNB -;=WW'ZKJIS0&,&>DL26<J/CDT@:B_:(M310^THDE=?G&>!\I\_O
M%K4J"\F?-V,I)V:C+5 D;5?008#NBQZ8-1W6=&CI\&Z:@M\?'?90F,N^1C'$
ME%C*!B0A'T<DB2=QDC=A]21JH9VLKD#1$9AR&H%X0FY51H!O*B(3S@%Q("5;
MR<8"G.ZA?@]T$_U%/77=?9I;( UMGZ6)U:*6#LZJ3C0BVSZ"4#<DP??F.:KH
MG9A,)28$TU*0"4=KT<B3/OGAY*(HWN2F2H,.<28,TT'&.QJS-WHBK5JH2WWZ
M\IY51D38$F1.520N>9CQBX8T9GXFKE<C?Y]1W"\1%V:@0I6Z/.<:QJ!F44M9
MU-,M8U%O*3\="?M,SH[%;QZVS[$XU6:*UM:E,G&8U5TQ:FR<[P*T]6K1?$3=
M]<],&3;=J]UH"UE)**B@JZ:VN07['QNVK2)()-N" I_G1,]2+WNN+G.!"!41
M-)R/P1:4HA0- CBYY/)$R[E1 L6B+INI318]A3'/*@!<,'PR;B68L[ P ^YD
MFX-<X0M([))>+W:<CS@!A2!A6)]$1X&>ACPI9X?3!QS$EW=ZJG-/%W)/7VP@
MZ.N+AYZ(NFREO[_LU!KT=8.E%<:QV*ZS=?/P#$/%;VB(Q+9WNNNAO%S(#+7M
MZHLBXWU$+9=)<AC4\:@J49S$6<(MH/"B_&M/M'#I'?"G:PG&(=J"KK10YF,$
M6RQ0B@%</W^<Z+1-0[XF48$%E_2Z6&,;QC0&>3DO=W89*MN7F$.(WO5@Q=J8
M(/ 88S'PL 80>RQ:6\X6PE4F5NNYM9Z[U5"RZZA5)GT-BF%J?2VRRF0H92$@
MEL#*WG(B13?N#)5%!RGBJ/.? DGR(9%0[1A9ZQCY:<L<(]U8?)!8:N?BXR M
M@)"R),?:R9. K,O4!^!9%T MW*15^" I9O1*O@<;;!3/:12WL3^U9)FZ,:U(
M"\NK#RNW<_/"ZGQ0A"KN5.BF1N$8DIQ8?%@,JRE:W(.8+5]X-%+/P"$R5)RP
MJWW8B T45<Q?6) @FQ!@->9O<4C<4(@8:9+8%*X^C<C)?1C(O$ )@CN0=7$/
M2X2B>%A2O69):UG2LRUC2;\J27DDQZ)3<D,5'"J0TSS5L\H"@'%1?]<XNE81
MXE\HVZ+!YPWEZF29\Y,X\=F&I=' :0]EKUC.B_)@#O*3>,A#S$P>Y^(<$HMY
MDC=^L! G?)+@X:7?5>E75DELW@;VGS N$C51H)E4G]S(LR!#/=$\V/5O6W9'
MHW1+ 78=SH_=W?^[= F.Q3 \_R .0YF8_$+XY^BG)\=++F]G26RHP8:[-D]X
M7;R:A^GB>\1\;?$X97"BOC;G/%%FD]7?7 I,2(OD/C"PB>L>Q?@Y49XMD_=T
M&^K$V!;R)A9AC):?8;^BN];VEO(F8W]9,G',[QUH1-+AD^7^GD4PZ+&>XN$9
MZF%*R9T!H0@]W?]QMQI#I>Q:2NH=2^QS;WL7E#KV7L>IR@U>%=H\) 1WH7?:
M1% '1%1>,9MR3+(^-G#R#/F#^<YP[H\=FW(YM8 :@<&K^1?*P" ,&:[[UTD^
M!O;T B>1HSSC8AJ'.K .YN6CPOUR"]7(?;]Y4C'F"]?R;QOA78Z:S[=,6/6R
MY%J#>LK"J6@-G!_$4I/@:HIAD?Z3UP 4J=ZE!'.N-P@"4AG[&,-7)1 -64H#
M]SJ3$]G<3'7BYR\9&K7-+RU^I Q#_]:%MD.(ZL0YXYA0[W+4!W'6M_D6,(:I
MLOF)DPFP+FR ?L8]%L1 F2#1?=98B]J%I\U^CGV%^1>DQ;(8QN,\U.C)0Q%.
MNCJ^Y3*>RQ 8P85*=#S@*<!6[_0SRZ(#D#\D#6R:1J4UNS])9ONE]LW/FX>X
M;(C\M6M5_S6[,HCI+44BOUM=GE.!745@594E9P"VU2N>8W^QKV]3(E'?Q&]-
MR."GC/9_@JT'VJ?K7K<AQ6J?=B?>*^;%TX._H%+U]/?6:>=$=+I7[<LNM5MH
MG8F=][W6+D+(?ZY3,9_(X;U/Y*Q]<=GIGHLWY^>G/7%R_NZBU?W]+DIPW;9\
M@7?8+<375V?_)6?CE]]M,39(RU(A]F/S6+R3R4?1AL<,9=)?5K-]W_^@'-^>
MXPIK^\KA+M!RZH]*G&;)1QUMPF(N+[]?7."M)ZB-&,2]GKRNG*@%NBYM].:0
M]G;1-*VL@$6MB?D!T-$5QAA7$5)IK4_:YYNP\7=X4C:7!I?O"O_O!5AY5'>W
M"8O[D"B5O%4NTXW'(98D*SYZ_?3QP?[CP_W#PUL,K_K0PUL_]+:6]]<=3_O^
M[SLG]&!_,P!)#_8?>B+HQN9\WA-IH4?WY-?VZ?NSMCC(>>86^]0*#+%O](+O
MCQD=; @S.JB9T8-G1JT+;#+8^8]H;2DS^L04OP5[V@CM:0E?.;P3OE(:V=<S
MF<,2D]E"MK*,1_R%)+*=9.ASFE\>**>I:_466=;1AJA"1[4J5*M"CD&=; *#
MVDXF",MX<8GMUB_;9^U6K[T)*_FU!B@!T"C1_L_>BQ?-^[;9/9(]:_6N]@H&
MM)1O?RT_?K(A_/C)&G[LV!'\T8\'<]B-<3H)7_]_4$L#!!0    ( #9/JU0W
M1CQVYPL  ,,O   -    97A?,S,V.#@P+FAT;>U:;7/;-A+^W/P*G#/7)C.2
M+=FIXTB*YU3'3M,FK>NX=W.?;D 2%%&#! N EM5??\\"($79CIMK>XF;:69:
MBR!>=A?/[CZ[TJQPI3J<%8)GAP\^FSGIE#@45__9V]L_.!AMX^UL)PSB[=^&
M0_925,)P)S*6K-AYT529,"]T*=BI-HXK-F1?[HS'.[NCW5TVWIWL/9V,G['Y
M&S8<'LY*X3A+"VZL<,^W&I</#[;B:,5+\7PKUZ;D;I@))U(G=;7%4ETY46&V
M$TK4A:[$\TIO'3Z8[0219XG.5LRZE?++*S>T\A<Q8>-1[:;,#^2\E&HU89__
MW&@W/9>EL.P[L61GNN15&)RRFF>9K!83-I(5&VV/935E:6.L-A/&&Z>G=&:]
M<5#<]XMK.WXQ78OAI?"/E]Q(7KE)11JJ:<G-0E83>KUU^'F5V'HZVZD/'[SC
MC&M'O,\)3ERY(5=R44V,7!2N=R1K_SOPQ\^2P^.K0B;2L6?/ML>SG>3P+ED^
MA+Z__XR9+!>,*P"'P#S>/_AR'R.CT7C[IWJQQ:Q)W_4F2+.4F2LFX_%X6@@R
MW^1@1+M^9+O<C>$^_)]T\&]/9/%(UD,&2^%;PDQ9E(/UT3'>O\=2 ;0O5CR3
M*9M7E6ZJ5-@@Z)FP@INT&+#7$OM8P7B5L2.M%$\T A>B"B0PS!6"O>%5D_/4
M-48PG;-?0_Y'TG->2:QD)T8(]JI:&)%)K+/W4=H/X=E_)!Y'[Z?Y3XUU,E]M
MJ Y)OOGQ]-7Y\=F G;QF.P#3:D9;M1(E/+U8&$ S&Z9:(8\\S/%O1&&$C1%E
M:>[A@%&B' 2=(J!?D9DKCU2N!GA,M]FCSQ\>[.Z.XA3_,)X.6!Q=BNLCC;T^
MHAO3#47XQS='NJQYM8IO'[-'W\W?OIC_,&$O_CU_]3C*QME"Z00P3*1&<BXJ
MJ+18(3W[M;!AVEAP G*NQF!SPV19&WV)G#I@O*[5*GR"+V:B5IH>F72685)M
M)"B 6=%G)Y!_\3=K/ %@M>*.6,& .9WQ%38(WIY! ^ZP RNX91Z9&).5TXRS
M;S0^L!?B4BA=EWC)YG ;X3^UENQ&.KV7TA58_#+H>:)UUG<W%LT$.:"!W]EK
M4_9B"&A,4R;0'<&$!Z_-R6MEMTVKFF6-)0O0-:1K^X^?3NV&A:6PVQ_;G7[_
M&3\22?2ZXII*2^:AA^X*)A]01<<3)1A2 41ZOC4"PQ1*1?;7/=N:I^WS)B$8
MC?X^_1^8&5CC9P\^ Z\V^$!_LW:_2V&<3+F*,<;I>AJ/.(CK,/W_99"'S_:?
M/@L6H6-V7/8>XMTETV\@J!L2G0,.)F9N\I&?P/_AD KQ1B"B*(400Z6&KSH(
M.[_FI4U-C@J?VMM_,MW;WF<04U% $8W1T:=ZJN,OW1#*"H^/OX!R7X$2<V0O
M"-^21-KD03?$E*QP8DOYRDW*=W>49BDBO,Q0[?Z%F#\[8GPP,2(5\A(I%R)P
M$(U,Y$!'UC*AMTV*.L*R$R'6_*FI@20C>%I0PFY7MBB[E&[E>0!O'Q3AT@9N
M()6P3A/^P%4RF>=@*9XA\H7HTF#:KTW^PMFGA#/>X]BE,*F$*+^$&A08BQ +
M] 1@4'K)?+.!Y7*! &4#]M+K:P.-YLSH%5= 7,U7GMK&+8A8 A^97%!H3'CD
MY>MMF.7J_2+:GYAS1L/_JX /,A0_\%B$>A-+%=Q0"3>VS-9"9"T3YYFN_>7
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M%[]M8N,#M4T0?/R/]_\+4$L! A0#%     @ -D^K5 A37-AV P  +PX  !$
M             ( !     &1Y86DM,C R,C U,3 N>'-D4$L! A0#%     @
M-D^K5'B/V?G=!   42T  !4              ( !I0,  &1Y86DM,C R,C U
M,3!?9&5F+GAM;%!+ 0(4 Q0    ( #9/JU1AB_41^P4  *L\   5
M      "  ;4(  !D>6%I+3(P,C(P-3$P7VQA8BYX;6Q02P$"% ,4    "  V
M3ZM4ZFK V7@$  #E+0  %0              @ 'C#@  9'EA:2TR,#(R,#4Q
M,%]P<F4N>&UL4$L! A0#%     @ -D^K5",T!P@B$P  H8(  !,
M     ( !CA,  &1Y86DR,#(R,#(Q-E\X:RYH=&U02P$"% ,4    "  V3ZM4
MD55MA_ V  #8T0$ #0              @ 'A)@  97A?,S,V.#<Y+FAT;5!+
M 0(4 Q0    ( #9/JU0W1CQVYPL  ,,O   -              "  ?Q=  !E
B>%\S,S8X.# N:'1M4$L%!@     '  < OP$   YJ      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
